Conformal prediction of HDAC inhibitors

References

• M. Mottamal, S. Zheng, T.L. Huang, and G. Wang, Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents, Molecules 20 (2015), pp. 3898–3941.
   Google Scholar
• R. Sangwana, R. Rajana, and P.K. Mandal, HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors, Eur. J. Med. Chem. 158 (2018), pp. 620–706.
   Web of Science ®Google Scholar
• H. Tang, X.S. Wang, X.-P. Huang, B.L. Roth, K.V. Butler, A.P. Kozikowski, M. Jung, and A. Tropsha, Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation, J. Chem. Inf. Model. 49 (2009), pp. 461–476.
   PubMed Web of Science ®Google Scholar
• H. Pham-The, G. Casañola-Martin, K. Diéguez-Santana, N. Nguyen-Hai, N.T. Ngoc, L. Vu-Duc, and H. Le-Thi-Thu, Quantitative structure–activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries, SAR QSAR Environ. Res. 28 (2017), pp. 199–220.
   Google Scholar
• M. Manal, K. Manish, D. Sanal, A. Selvaraj, V. Devadasan, and M.J.N. Chandrasekar, Novel HDAC8 inhibitors: A multi-computational approach, SAR QSAR Environ. Res. 28 (2017), pp. 707–733.
   Google Scholar
• S. Sinha, C. Tyagi, S. Goyal, S. Jamal, P. Somvanshi, and A. Grover, Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia, J. Biomol. Struct. Dyn. 34 (2016), pp. 2281–2295.
   PubMed Web of Science ®Google Scholar
• S. Sinha, S. Goyal, P. Somvanshi, and A. Grover, Mechanistic insights into the binding of class IIa HDAC inhibitors toward spinocerebellar ataxia type-2: A 3D-QSAR and pharmacophore modeling approach, Front. Neurosci. 10 (2017), pp. 606.
   Google Scholar
• Z. Noor, N. Afzal, and S. Rashid, Exploration of novel inhibitors for class I histone deacetylase isoforms by QSAR modeling and molecular dynamics simulation assays, PLoS ONE 10 (2015), pp. e0139588.
   Google Scholar
• M.M. Abdel-Atty, N.A. Farag, S.E. Kassab, R.A.T. Serya, and K.A.M. Abouzid, Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as histone deacetylase inhibitors and cytotoxic agents, Bioorg. Chem. 57 (2014), pp. 65–82.
   Web of Science ®Google Scholar
• R. Ragno, S. Simeoni, S. Valente, S. Massa, and A. Mai, 3-D QSAR studies on histone deacetylase inhibitors. A GOLPE/GRID approach on different series of compounds, J. Chem. Inf. Model. 46 (2006), pp. 1420–1430.
   Google Scholar
• J.J. Naveja and J.L. Medina-Franco, Insights from pharmacological similarity of epigenetic targets in epipolypharmacology, Drug Discov. Today 23 (2018), pp. 141–150.
   Google Scholar
• A. Gaulton, A. Hersey, M. Nowotka, A.P. Bento, J. Chambers, D. Mendez, P. Mutowo, F. Atkinson, L.J. Bellis, E. Cibrián-Uhalte, M. Davies, N. Dedman, A. Karlsson, M.P. Magariños, J.P. Overington, G. Papadatos, I. Smit, and A.R. Leach, The ChEMBL database in 2017, Nucleic Acids Res. 45 (2017), pp. D945–D954.
   Google Scholar
• D.S. Wishart, C. Knox, A.C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, and J. Woolsey, DrugBank: A comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res. 34 (2006), pp. D668–D672.
   Google Scholar
• B.L. Roth, E. Lopez, S. Patel, and W.K. Kroeze, The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches? Neuroscientist 6 (2000), pp. 252–262.
   Google Scholar
• Z. Feng, L. Chen, H. Maddula, O. Akcan, R. Oughtred, H.M. Berman, and J. Westbrook, Ligand Depot: A data warehouse for ligands bound to macromolecules, Bioinformatics 20 (2004), pp. 2153–2155.
   Google Scholar
• M.K. Gilson, T. Liu, M. Baitaluk, G. Nicola, L. Hwang, and J. Chong, BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology, Nucleic Acids Res. 44 (2016), pp. D1045–D1053.
   Google Scholar
• D. Wishart, D. Arndt, A. Pon, T. Sajed, A.C. Guo, Y. Djoumbou, C. Knox, M. Wilson, Y. Liang, J. Grant, Y. Liu, S.A. Goldansaz, and S.M. Rappaport, T3DB: The toxic exposome database, Nucleic Acids Res. 43 (2015), pp. D928–D934.
   Google Scholar
• F. Zhu, Z. Shi, C. Qin, L. Tao, X. Liu, F. Xu, L. Zhang, Y. Song, X. Liu, J. Zhang, B. Han, P. Zhang, and Y. Chen, Therapeutic target database update 2012: A resource for facilitating target-oriented drug discovery, Nucleic Acids Res. 40 (2012), pp. D1128–D1136.
   Google Scholar
• EBI standardizer. Francis Atkinson, version 0.1.9, EBI.  Software available at https://pypi.python.org/pypi/standardiser, https://wwwdev.ebi.ac.uk/chembl/extra/francis/standardiser/.
   Google Scholar
• MolVS (2014). Matt Swain, version 0.0.3. Software available at https://pypi.python.org/pypi/MolVS.
   Google Scholar
• RDKit, Open-Source Cheminformatics. Greg Landrum, version 2016_03_1.  Software available at http://www.rdkit.org.
   Google Scholar
• V. Vovk, A. Gammerman, and G. Shafer, Algorithmic Learning In A Random World, Springer, New York, 2005.
   Google Scholar
• U. Norinder, L. Carlsson, S. Boyer, and M. Eklund, Introducing conformal prediction in predictive modeling. A transparent and flexible alternative to applicability domain determination. J. Chem. Inf. Model. 54 (2014), pp. 1596−1603.
   Google Scholar
• U. Norinder, G. Myatt, and E. Ahlberg, Predicting aromatic amine mutagenicity with confidence: A case study using conformal prediction, Biomolecules 8 (2018), pp. 85.
   Google Scholar
• G. Shafer and V. Vovk, A tutorial on conformal prediction, J. Mach. Learn. Res. 9 (2008), pp. 371–421.
   Web of Science ®Google Scholar
• L. Carlsson, M. Eklund, and U. Norinder, Aggregated conformal prediction, in Artificial Intelligence Applications and Innovations, IFIP Advances in Information and Communication Technology, L. Iliadis, I. Maglogiannis, H. Papadopoulos, S. Sioutas, and C. Makris C, eds., Springer, Berlin Heidelberg, (2014), pp. 231–240.
   Google Scholar
• F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, J. Vanderplas, A. Passos, D. Cournapeau, M. Brucher, M. Perrot, and É. Duchesnay, Scikit-learn: Machine learning in Python, J. Mach. Learn. Res. 12 (2011), pp. 2825–2830.
   Web of Science ®Google Scholar
• Nonconformist package 1.2.5. Henrik Linusson, version 1.2.5.  Software available at https://github.com/donlnz/nonconformist.
   Google Scholar
• L. Breiman, Random forests, Machine Learn. 45 (2001), pp. 5–32.
   Web of Science ®Google Scholar
• E. Pontiki and D. Hadjipavlou-Litina, Histone deacetylase inhibitors (HDACIs). Structure–activity relationships: History and new QSAR perspectives, Med. Res. Rev. 32 (2012), pp. 1–165.
   Google Scholar
• X.H. Liu, H.Y. Song, J.X. Zhang, B.C. Han, X.N. Wei, X.H. Ma, W.K. Cui, and Y.Z. Chen, Identifying novel type ZBGs and nonhydroxamate HDAC inhibitors through a SVM based virtual screening approach, Mol. Inf. 29 (2010), pp. 407–420.
   Google Scholar
• L. Zhao, Y. Xiang, J. Song, and Z. Zhang, A novel two-step QSAR modeling work flow to predict selectivity and activity of HDAC inhibitors, Bioorg. Med. Chem. Lett. 23 (2013), pp. 929–933.
   PubMed Web of Science ®Google Scholar
• J. Shi, G. Zhao, and Y. Wei, Computational QSAR model combined molecular descriptors and fingerprints to predict HDAC1 inhibitors, Med. Sci. (Paris) 34 (2018), pp. 52–58.
   PubMed Web of Science ®Google Scholar